Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $124,670,210    

Indirect Value

   $39,932,089      
Total Shares   87,362,343      
Total Value   $164,602,299      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $32,927,720 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,282,186 Achieve Life Sciences Inc $4,493,107 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $116,287 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $19,744,711 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $32,927,720 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,282,186 Achieve Life Sciences Inc $4,493,107 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $116,287 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $19,744,711 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 15 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-01-08 4 B $3.70 $1,849 I/I 500 18,155,803 2.17 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-09-21 4 B $0.79 $1,853 D/D 2,360 15,966,865 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-01-09 4 B $3.79 $2,064 I/I 545 18,156,348 2.17 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-04-20 4 B $3.59 $2,156 D/D 600 16,213,811 3.84 -
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-09-22 4 S $0.15 $2,550 D/D (17,000) 15,899,492 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-31 4 B $4.21 $2,757 D/D 655 16,480,000 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-01-10 4 B $3.70 $2,958 I/I 800 18,157,148 2.17 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-03-23 4 B $2.52 $3,462 I/I 1,374 716,000 2.17 %
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-08-31 4 S $0.11 $3,850 D/D (35,000) 18,861,787 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-03-19 4 B $2.60 $4,074 I/I 1,567 705,000 2.17 %
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2018-02-05 4 B $1.14 $4,560 D/D 4,000 6,928,000 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-09-18 4 B $0.78 $4,667 D/D 6,000 15,919,136 3.84 -
FRTX Fresh Tracks Therapeutics... 10% Owner   –       –       •   2018-06-20 4 B $1.27 $4,685 D/D 3,702 3,017,444 2.37 -
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-09-24 4 S $0.13 $4,973 D/D (38,257) 15,811,235 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-10-16 4 B $1.08 $5,174 D/D 4,800 16,004,800 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-30 4 B $3.97 $5,559 D/D 1,400 17,765,000 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-09-29 4 B $0.87 $5,986 D/D 6,883 16,000,000 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-05 4 B $4.32 $6,471 D/D 1,497 17,503,912 3.84 -
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-08-27 4 S $0.12 $6,632 D/D (55,263) 18,971,787 0 %
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-05-07 4 B $0.48 $6,888 D/D 14,252 16,512,500 2.37 -
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-09-23 4 S $0.14 $7,000 D/D (50,000) 15,849,492 0 %
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2018-08-20 4 S $0.91 $7,254 D/D (8,000) 2,164,000 0 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-04 4 B $3.40 $7,488 D/D 2,200 18,003,600 3.84 -
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-08-28 4 S $0.11 $8,250 D/D (75,000) 18,896,787 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-19 4 B $3.50 $8,280 D/D 2,298 18,441,469 3.84 -
  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15  16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32      
  Page 15 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us